Healthcare provider profile · identity verified

Alan Paul Levine, M.D.

Internal Medicine · READING, PA · NPI 1447279021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	680	193
Amlodipine Besylate	Amlodipine Besylate	458	127
Lisinopril	Lisinopril	449	135
Levothyroxine Sodium	Levothyroxine Sodium	428	116
Simvastatin	Simvastatin	322	90
Omeprazole	Omeprazole	315	100
Sertraline Hcl	Sertraline Hcl	261	67
Metoprolol Tartrate	Metoprolol Tartrate	236	61
Losartan Potassium	Losartan Potassium	234	71
Metformin Hcl	Metformin Hcl	227	68
Metoprolol Succinate	Metoprolol Succinate	225	61
Pantoprazole Sodium	Pantoprazole Sodium	181	54
Rosuvastatin Calcium	Rosuvastatin Calcium	165	53
Hydrochlorothiazide	Hydrochlorothiazide	148	46
Tamsulosin Hcl	Tamsulosin Hcl	138	43
Gabapentin	Gabapentin	133	43
Eliquis	Apixaban	131	37
Synthroid	Levothyroxine Sodium	129	34
Alprazolam	Alprazolam	118	32
Lorazepam	Lorazepam	117	33
Potassium Chloride	Potassium Chloride	115	34
Furosemide	Furosemide	109	39
Allopurinol	Allopurinol	94	28
Albuterol Sulfate Hfa	Albuterol Sulfate	91	32
Glimepiride	Glimepiride	90	25
Atenolol	Atenolol	85	28
Pravastatin Sodium	Pravastatin Sodium	81	24
Montelukast Sodium	Montelukast Sodium	77	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	suppressed
Tramadol Hcl	Tramadol Hcl	69	30
Zolpidem Tartrate	Zolpidem Tartrate	65	19
Famotidine	Famotidine	63	18
Meloxicam	Meloxicam	62	19
Clopidogrel	Clopidogrel Bisulfate	59	20
Januvia	Sitagliptin Phosphate	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	55	22
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	51	12
Jardiance	Empagliflozin	51	suppressed
Metformin Hcl Er	Metformin Hcl	50	12
Ramipril	Ramipril	48	14
Hydralazine Hcl	Hydralazine Hcl	46	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	11
Duloxetine Hcl	Duloxetine Hcl	43	13
Finasteride	Finasteride	43	14
Xarelto	Rivaroxaban	43	suppressed
Bupropion Xl	Bupropion Hcl	42	11
Clonazepam	Clonazepam	42	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	40	suppressed
Alendronate Sodium	Alendronate Sodium	40	12
Carvedilol	Carvedilol	40	14
Diazepam	Diazepam	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Valsartan	Valsartan	35	12
Ezetimibe	Ezetimibe	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Aripiprazole	Aripiprazole	32	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	12
Lovastatin	Lovastatin	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Nystatin	Nystatin	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	14
Ozempic	Semaglutide	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Colesevelam Hcl	Colesevelam Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Farxiga	Dapagliflozin Propanediol	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Topiramate	Topiramate	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Toprol Xl	Metoprolol Succinate	16	suppressed
Amoxicillin	Amoxicillin	15	14
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Nitroglycerin	Nitroglycerin	14	14
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cevimeline Hcl	Cevimeline Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Dutasteride	Dutasteride	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Demeclocycline Hcl	Demeclocycline Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error